Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology

Amin, NB; Saxena, AR; Somayaji, V; Dullea, R

Dullea, R (通讯作者),Pfizer Inc, Internal Med Res Unit, Cambridge, MA 02139 USA.

CLINICAL THERAPEUTICS, 2023; 45 (1): 55

Abstract

Purpose: Hepatic steatosis due to altered lipid metabolism and accumulation of hepatic triglycerides is a hallmark of nonalcoholic fatty liver disease......

Full Text Link